A novel artificial intelligence network to assess the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features

Gastrointestinal cancer
DOI: 10.3389/fimmu.2024.1428529 Publication Date: 2024-06-27T04:34:14Z
ABSTRACT
Immune checkpoint inhibitors (ICIs) have revolutionized gastrointestinal cancer treatment, yet the absence of reliable biomarkers hampers precise patient response prediction.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (7)